BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Cutaneous rash
1
First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer
9/15/2014 8:54:00 PM | Browse: 1253 | Download: 1093
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345